{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T04:50:07Z","timestamp":1793508607130,"version":"4.5.0"},"reference-count":59,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"am","delay-in-days":273,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Institutes of Health National Cancer Institute","doi-asserted-by":"publisher","award":["P30CA016672"],"award-info":[{"award-number":["P30CA016672"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012394","name":"Robert J. Kleberg, Jr. and Helen C. Kleberg Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012394","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000923","name":"Australian Research Council","doi-asserted-by":"publisher","award":["DP180101581"],"award-info":[{"award-number":["DP180101581"]}],"id":[{"id":"10.13039\/501100000923","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000923","name":"Australian Research Council","doi-asserted-by":"publisher","award":["CE140100003"],"award-info":[{"award-number":["CE140100003"]}],"id":[{"id":"10.13039\/501100000923","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["UG3NS127251"],"award-info":[{"award-number":["UG3NS127251"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["RF1NS113840"],"award-info":[{"award-number":["RF1NS113840"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brain, Behavior, and Immunity"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.bbi.2025.06.037","type":"journal-article","created":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T13:21:48Z","timestamp":1751376108000},"page":"547-556","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Targeted activation of Nrf2 at sites of oxidative stress reverses doxorubicin-induced cognitive impairments in mice"],"prefix":"10.1016","volume":"129","author":[{"given":"Anand K.","family":"Singh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Ruiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vipul K.","family":"Pandey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohd Sami","family":"Ur Rasheed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dion J.L.","family":"Turner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas D.","family":"Avery","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew D.","family":"Abell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8999-1220","authenticated-orcid":false,"given":"Peter M.","family":"Grace","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbi.2025.06.037_b0005","doi-asserted-by":"crossref","first-page":"6332","DOI":"10.1523\/JNEUROSCI.0426-16.2016","article-title":"Distinct Nrf2 Signaling Mechanisms of Fumaric Acid Esters and Their Role in Neuroprotection against 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine-Induced Experimental Parkinson's-Like Disease","volume":"36","author":"Ahuja","year":"2016","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bbi.2025.06.037_b0010","doi-asserted-by":"crossref","first-page":"3109","DOI":"10.7150\/thno.53474","article-title":"Nasal administration of mitochondria reverses chemotherapy-induced cognitive deficits","volume":"11","author":"Alexander","year":"2021","journal-title":"Theranostics"},{"key":"10.1016\/j.bbi.2025.06.037_b0015","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1080\/15376516.2019.1600086","article-title":"Doxorubicin-induced neurotoxicity is associated with acute alterations in synaptic plasticity, apoptosis, and lipid peroxidation","volume":"29","author":"Alhowail","year":"2019","journal-title":"Toxicol. Mech. Methods"},{"key":"10.1016\/j.bbi.2025.06.037_b0020","doi-asserted-by":"crossref","DOI":"10.1038\/s41587-024-02460-4","article-title":"Site-specific drug release of monomethyl fumarate to treat oxidative stress disorders","author":"Avery","year":"2024","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.bbi.2025.06.037_b0025","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1080\/14737175.2023.2187288","article-title":"Cancer-related cognitive impairment: current perspectives on the management of cognitive changes following cancer treatment","volume":"23","author":"Binarelli","year":"2023","journal-title":"Expert Rev. Neurother."},{"key":"10.1016\/j.bbi.2025.06.037_b0030","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1080\/13548506.2018.1500023","article-title":"Women's experiences of cancer-related cognitive impairment, its impact on daily life and care received for it following treatment for breast cancer","volume":"23","author":"Bolton","year":"2018","journal-title":"Psychol. Health Med."},{"key":"10.1016\/j.bbi.2025.06.037_b0035","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1038\/nchembio782","article-title":"Elevated levels of oxidized cholesterol metabolites in Lewy body disease brains accelerate alpha-synuclein fibrilization","volume":"2","author":"Bosco","year":"2006","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.bbi.2025.06.037_b0040","first-page":"217","article-title":"White matter disease induced by high-dose chemotherapy: longitudinal study with MR imaging and proton spectroscopy","volume":"19","author":"Brown","year":"1998","journal-title":"AJNR Am. J. Neuroradiol."},{"key":"10.1016\/j.bbi.2025.06.037_b0045","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/S0891-5849(97)00104-4","article-title":"Protein carbonyl measurement by a sensitive ELISA method","volume":"23","author":"Buss","year":"1997","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.bbi.2025.06.037_b0050","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1310\/hpj4808-668","article-title":"Dimethyl fumarate","volume":"48","author":"Cada","year":"2013","journal-title":"Hosp. Pharm."},{"key":"10.1016\/j.bbi.2025.06.037_b0055","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1089\/ars.2016.6800","article-title":"The Neuroprotective Effect of Dimethyl Fumarate in an MPTP-Mouse Model of Parkinson's Disease: Involvement of Reactive Oxygen Species\/Nuclear Factor-kappaB\/Nuclear Transcription Factor Related to NF-E2","volume":"27","author":"Campolo","year":"2017","journal-title":"Antioxid. Redox Signal."},{"key":"10.1016\/j.bbi.2025.06.037_b0060","doi-asserted-by":"crossref","first-page":"3081","DOI":"10.1038\/s41467-019-11139-3","article-title":"Therapeutic efficacy of dimethyl fumarate in relapsing-remitting multiple sclerosis associates with ROS pathway in monocytes","volume":"10","author":"Carlstrom","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bbi.2025.06.037_b0065","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1158\/0008-5472.CAN-16-1817","article-title":"Pifithrin-mu Prevents Cisplatin-Induced Chemobrain by Preserving Neuronal Mitochondrial Function","volume":"77","author":"Chiu","year":"2017","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbi.2025.06.037_b0070","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.jchromb.2015.11.052","article-title":"A step-by-step protocol for assaying protein carbonylation in biological samples","volume":"1019","author":"Colombo","year":"2016","journal-title":"J. Chromatogr. B Anal. Technol. Biomed. Life Sci."},{"key":"10.1016\/j.bbi.2025.06.037_b0075","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1177\/1534735404270335","article-title":"Chemotherapy-associated oxidative stress: impact on chemotherapeutic effectiveness","volume":"3","author":"Conklin","year":"2004","journal-title":"Integr. Cancer Ther."},{"key":"10.1016\/j.bbi.2025.06.037_b0080","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1124\/pr.117.014753","article-title":"Transcription Factor NRF2 as a Therapeutic Target for Chronic Diseases: A Systems Medicine Approach","volume":"70","author":"Cuadrado","year":"2018","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.bbi.2025.06.037_b0085","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1038\/s41573-018-0008-x","article-title":"Therapeutic targeting of the NRF2 and KEAP1 partnership in chronic diseases","volume":"18","author":"Cuadrado","year":"2019","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.bbi.2025.06.037_b0090","doi-asserted-by":"crossref","first-page":"2492","DOI":"10.1056\/NEJMoa1306033","article-title":"Bardoxolone methyl in type 2 diabetes and stage 4 chronic kidney disease","volume":"369","author":"de Zeeuw","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bbi.2025.06.037_b0095","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.freeradbiomed.2006.11.013","article-title":"Gp91phox-containing NAD(P)H oxidase increases superoxide formation by doxorubicin and NADPH","volume":"42","author":"Deng","year":"2007","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.bbi.2025.06.037_b0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2024.e31608","article-title":"Doxorubicin-induced neurotoxicity differently affects the hippocampal formation subregions in adult mice","volume":"10","author":"Dias-Carvalho","year":"2024","journal-title":"Heliyon"},{"key":"10.1016\/j.bbi.2025.06.037_b0105","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.tips.2022.12.003","article-title":"Advances and challenges in therapeutic targeting of NRF2","volume":"44","author":"Dinkova-Kostova","year":"2023","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.bbi.2025.06.037_b0110","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1038\/nrn.2017.74","article-title":"Prefrontal-hippocampal interactions in episodic memory","volume":"18","author":"Eichenbaum","year":"2017","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.bbi.2025.06.037_b0115","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/BF02790108","article-title":"Lipid peroxidation products, and vitamin and trace element status in patients with cancer before and after chemotherapy, including adriamycin. A preliminary study","volume":"47","author":"Faber","year":"1995","journal-title":"Biol. Trace Elem. Res."},{"issue":"43\u201355","key":"10.1016\/j.bbi.2025.06.037_b0120","first-page":"e13","article-title":"Methotrexate Chemotherapy Induces Persistent Tri-glial Dysregulation that Underlies Chemotherapy-Related Cognitive Impairment","volume":"176","author":"Gibson","year":"2019","journal-title":"Cell"},{"key":"10.1016\/j.bbi.2025.06.037_b0125","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1159\/000519829","article-title":"Routine Cancer Treatment Regimens and Its Impact on Fine Motor Dexterity in Breast Cancer","volume":"45","author":"Grusdat","year":"2022","journal-title":"Oncol. Res. Treat."},{"key":"10.1016\/j.bbi.2025.06.037_b0130","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.tibs.2014.02.002","article-title":"The Nrf2 regulatory network provides an interface between redox and intermediary metabolism","volume":"39","author":"Hayes","year":"2014","journal-title":"Trends Biochem. Sci"},{"key":"10.1016\/j.bbi.2025.06.037_b0135","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.tips.2021.01.004","article-title":"Emerging Therapeutic Applications for Fumarates","volume":"42","author":"Hoogendoorn","year":"2021","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.bbi.2025.06.037_b0140","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/0891-5849(90)90131-2","article-title":"Malondialdehyde and thiobarbituric acid-reactivity as diagnostic indices of lipid peroxidation and peroxidative tissue injury","volume":"9","author":"Janero","year":"1990","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.bbi.2025.06.037_b0145","doi-asserted-by":"crossref","first-page":"41","DOI":"10.3389\/fnmol.2020.00041","article-title":"Oxidative Stress in Cognitive and Epigenetic Aging: A Retrospective Glance","volume":"13","author":"Kandlur","year":"2020","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.bbi.2025.06.037_b0150","doi-asserted-by":"crossref","first-page":"30324","DOI":"10.18632\/oncotarget.25718","article-title":"Doxorubicin-induced elevated oxidative stress and neurochemical alterations in brain and cognitive decline: protection by MESNA and insights into mechanisms of chemotherapy-induced cognitive impairment (\u201cchemobrain\u201d)","volume":"9","author":"Keeney","year":"2018","journal-title":"Oncotarget"},{"key":"10.1016\/j.bbi.2025.06.037_b0155","doi-asserted-by":"crossref","first-page":"7130","DOI":"10.1128\/MCB.24.16.7130-7139.2004","article-title":"Oxidative stress sensor Keap1 functions as an adaptor for Cul3-based E3 ligase to regulate proteasomal degradation of Nrf2","volume":"24","author":"Kobayashi","year":"2004","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.bbi.2025.06.037_b0160","doi-asserted-by":"crossref","first-page":"760","DOI":"10.7150\/ijbs.65258","article-title":"Underlying the Mechanisms of Doxorubicin-Induced Acute Cardiotoxicity: Oxidative Stress and Cell Death","volume":"18","author":"Kong","year":"2022","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.bbi.2025.06.037_b0165","doi-asserted-by":"crossref","first-page":"5441","DOI":"10.1007\/s12035-023-03910-x","article-title":"Wnt3a\/GSK3beta\/beta-catenin Signalling Modulates Doxorubicin-associated Memory Deficits in Breast Cancer","volume":"61","author":"Li","year":"2024","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.bbi.2025.06.037_b0170","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1146\/annurev-neuro-102423-100258","article-title":"Learning, Fast and Slow: Single- and Many-Shot Learning in the Hippocampus","volume":"47","author":"Liao","year":"2024","journal-title":"Annu. Rev. Neurosci."},{"key":"10.1016\/j.bbi.2025.06.037_b0175","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1093\/brain\/awq386","article-title":"Fumaric acid esters exert neuroprotective effects in neuroinflammation via activation of the Nrf2 antioxidant pathway","volume":"134","author":"Linker","year":"2011","journal-title":"Brain"},{"key":"10.1016\/j.bbi.2025.06.037_b0180","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.adf8977","article-title":"Targeting ryanodine receptor type 2 to mitigate chemotherapy-induced neurocognitive impairments in mice","volume":"15","author":"Liu","year":"2023","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.bbi.2025.06.037_b0185","doi-asserted-by":"crossref","first-page":"e1171","DOI":"10.1038\/tp.2017.138","article-title":"Oxidative stress, prefrontal cortex hypomyelination and cognitive symptoms in schizophrenia","volume":"7","author":"Maas","year":"2017","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.bbi.2025.06.037_b0190","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.bbr.2016.04.012","article-title":"Dimethyl fumarate attenuates intracerebroventricular streptozotocin-induced spatial memory impairment and hippocampal neurodegeneration in rats","volume":"308","author":"Majkutewicz","year":"2016","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.bbi.2025.06.037_b0195","doi-asserted-by":"crossref","unstructured":"Maynard, S., Fang, E.F., Scheibye-Knudsen, M., Croteau, D.L., Bohr, V.A., 2015. DNA Damage, DNA Repair, Aging, and Neurodegeneration. Cold Spring Harb Perspect Med 5.","DOI":"10.1101\/cshperspect.a025130"},{"key":"10.1016\/j.bbi.2025.06.037_b0200","doi-asserted-by":"crossref","first-page":"603","DOI":"10.7150\/thno.67410","article-title":"HDAC6 inhibition reverses long-term doxorubicin-induced cognitive dysfunction by restoring microglia homeostasis and synaptic integrity","volume":"12","author":"McAlpin","year":"2022","journal-title":"Theranostics"},{"key":"10.1016\/j.bbi.2025.06.037_b0205","first-page":"409","article-title":"Cancer treatment and survivorship statistics, 2022","volume":"72","author":"Miller","year":"2022","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.bbi.2025.06.037_b0210","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1177\/1352458519881761","article-title":"Diroximel fumarate (DRF) in patients with relapsing-remitting multiple sclerosis: Interim safety and efficacy results from the phase 3 EVOLVE-MS-1 study","volume":"26","author":"Naismith","year":"2020","journal-title":"Mult. Scler."},{"key":"10.1016\/j.bbi.2025.06.037_b0215","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.202012075","article-title":"Cellular mechanisms and treatments for chemobrain: insight from aging and neurodegenerative diseases","volume":"12","author":"Nguyen","year":"2020","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.bbi.2025.06.037_b0220","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1089\/ars.2007.1632","article-title":"Mitochondrial and nuclear p53 localization in cardiomyocytes: redox modulation by doxorubicin (Adriamycin)?","volume":"9","author":"Nithipongvanitch","year":"2007","journal-title":"Antioxid. Redox Signal."},{"key":"10.1016\/j.bbi.2025.06.037_b0225","doi-asserted-by":"crossref","first-page":"5911","DOI":"10.1038\/s41467-020-19593-0","article-title":"Enhancer remodeling promotes tumor-initiating activity in NRF2-activated non-small cell lung cancers","volume":"11","author":"Okazaki","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bbi.2025.06.037_b0230","doi-asserted-by":"crossref","DOI":"10.1016\/j.neubiorev.2023.105198","article-title":"Methodological shortcomings of preclinical research on chemotherapy-induced cognitive impairment","volume":"150","author":"Ossorio-Salazar","year":"2023","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.bbi.2025.06.037_b0235","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.phrs.2017.01.001","article-title":"Dysregulation of cytokine mediated chemotherapy induced cognitive impairment","volume":"117","author":"Ren","year":"2017","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.bbi.2025.06.037_b0240","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1002\/glia.20947","article-title":"Nrf2 regulates microglial dynamics and neuroinflammation in experimental Parkinson's disease","volume":"58","author":"Rojo","year":"2010","journal-title":"Glia"},{"key":"10.1016\/j.bbi.2025.06.037_b0245","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1007\/s00403-010-1061-4","article-title":"Pharmacokinetics of anti-psoriatic fumaric acid esters in psoriasis patients","volume":"302","author":"Rostami-Yazdi","year":"2010","journal-title":"Arch. Dermatol. Res."},{"key":"10.1016\/j.bbi.2025.06.037_b0250","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1111\/j.1468-1331.2006.01292.x","article-title":"Oral fumaric acid esters for the treatment of active multiple sclerosis: an open-label, baseline-controlled pilot study","volume":"13","author":"Schimrigk","year":"2006","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.bbi.2025.06.037_b0255","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s40478-022-01315-w","article-title":"Targeting the A3 adenosine receptor to prevent and reverse chemotherapy-induced neurotoxicities in mice","volume":"10","author":"Singh","year":"2022","journal-title":"Acta Neuropathol. Commun."},{"key":"10.1016\/j.bbi.2025.06.037_b0260","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1038\/nn.4650","article-title":"The hippocampus as a predictive map","volume":"20","author":"Stachenfeld","year":"2017","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.bbi.2025.06.037_b0265","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.freeradbiomed.2015.06.006","article-title":"Molecular basis of the Keap1-Nrf2 system","volume":"88","author":"Suzuki","year":"2015","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.bbi.2025.06.037_b0270","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.3233\/JAD-161088","article-title":"Oxidative Stress, Synaptic Dysfunction, and Alzheimer's Disease","volume":"57","author":"Tonnies","year":"2017","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.bbi.2025.06.037_b0275","doi-asserted-by":"crossref","first-page":"14431","DOI":"10.1038\/s41598-023-40877-0","article-title":"Enhanced presynaptic mitochondrial energy production is required for memory formation","volume":"13","author":"Underwood","year":"2023","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbi.2025.06.037_b0280","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/s11910-012-0264-9","article-title":"Chemotherapy-related cognitive dysfunction","volume":"12","author":"Wefel","year":"2012","journal-title":"Curr. Neurol. Neurosci. Rep."},{"key":"10.1016\/j.bbi.2025.06.037_b0285","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1152\/physrev.00023.2017","article-title":"The KEAP1-NRF2 System: a Thiol-Based Sensor-Effector Apparatus for Maintaining Redox Homeostasis","volume":"98","author":"Yamamoto","year":"2018","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.bbi.2025.06.037_b0290","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.biopha.2008.01.017","article-title":"Glutathione and Parkinson's disease: is this the elephant in the room?","volume":"62","author":"Zeevalk","year":"2008","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.bbi.2025.06.037_b0295","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1210\/en.2017-00752","article-title":"Nrf2 Deficiency Upregulates Intrarenal Angiotensin-Converting Enzyme-2 and Angiotensin 1-7 Receptor Expression and Attenuates Hypertension and Nephropathy in Diabetic Mice","volume":"159","author":"Zhao","year":"2018","journal-title":"Endocrinology"}],"container-title":["Brain, Behavior, and Immunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889159125002545?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889159125002545?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T20:52:31Z","timestamp":1759611151000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889159125002545"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":59,"alternative-id":["S0889159125002545"],"URL":"https:\/\/doi.org\/10.1016\/j.bbi.2025.06.037","relation":{},"ISSN":["0889-1591"],"issn-type":[{"value":"0889-1591","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Targeted activation of Nrf2 at sites of oxidative stress reverses doxorubicin-induced cognitive impairments in mice","name":"articletitle","label":"Article Title"},{"value":"Brain, Behavior, and Immunity","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbi.2025.06.037","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}